The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Associations of Insulin Resistance and Adiponectin With Mortality in Women With Breast Cancer
Open accessAbstract
Purpose: Overweight or obese breast cancer patients have a worse prognosis compared with normal-weight patients. This may be attributed to hyperinsulinemia and dysregulation of adipokine levels associated with overweight and obesity. Here, we evaluate whether low levels of adiponectin and a greater level of insulin resistance are associated with breast cancer mortality and all-cause mortality. Patients and Methods: We measured glucose, insulin, and adiponectin levels in fasting serum samples from 527 women enrolled in the Health, Eating, Activity, and Lifestyle (HEAL) Study, a multiethnic, prospective cohort study of women diagnosed with stage I-IIIA breast cancer. We evaluated the association between adiponectin and insulin and glucose levels (expressed as the Homeostatic Model Assessment [HOMA] score) represented as continuous measures and median split categories, along with breast cancer mortality and all-cause mortality, using Cox proportional hazards models. Results: Increasing HOMA scores were associated with reduced breast cancer survival (hazard ratio [HR], 1.12; 95% CI, 1.05 to 1.20) and reduced all-cause survival (HR, 1.09; 95% CI, 1.02 to 1.15) after adjustment for possible confounders. Higher levels of adiponectin (above the median: 15.5 μg/mL) were associated with longer breast cancer survival (HR, 0.39; 95% CI, 0.15 to 0.95) after adjustment for covariates. A continuous measure of adiponectin was not associated with either breast cancer–specific or all-cause mortality. Conclusion: Elevated HOMA scores and low levels of adiponectin, both associated with obesity, were associated with increased breast cancer mortality. To the best of our knowledge, this is the first demonstration of the association between low levels of adiponectin and increased breast cancer mortality in breast cancer survivors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“Metformin acts through the AMPK/mTOR/S6K1 axis,(53) and observational cohort studies suggest that metformin is associated with reduced risk of cancer in patients with type 2 diabetes.(54-56) Diabetic breast cancer patients using metformin, an insulin-lowering medication, experience a higher rate of pathologic complete…”
BackgroundNew Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880 · cited 1×
“04).(57) This has prompted clinical trials of metformin, including a trial of neoadjuvant chemotherapy and trastuzumab with or without metformin in women diagnosed with HER2-positive primary breast cancer.”
BackgroundRisk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration
UK Hypoglycaemia Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0599-y · Cited by 825
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Rohan, T. E., Manson, J. E., Li, J., Ho, G. Y. F., Xue, X., Anderson, G. L., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn415 · Cited by 563
Adiponectin and Breast Cancer Risk
Mantzoros, C., Petridou, E., Dessypris, N., Chavelas, C., Dalamaga, M., Alexe, D. M., Papadiamantis, Y., Markopoulos, C., Spanos, E., Chrousos, G., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031804 · Cited by 533
Matsubara, M., Maruoka, S., & Katayose, S. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470173 · Cited by 509
The Challenge of Subgroup Analyses — Reporting without Distorting
Lagakos, S. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068070 · Cited by 504
Association of serum adiponectin levels with breast cancer risk.
Miyoshi, Y., Funahashi, T., Kihara, S., Taguchi, T., Tamaki, Y., Matsuzawa, Y., & Noguchi, S. (2003) · PubMed · Cited by 503
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes
Landman, G. W. D., Kleefstra, N., van Hateren, K. J. J., Groenier, K. H., Gans, R. O. B., & Bilo, H. J. G. (2010) · Diabetes Care · doi:10.2337/dc09-1380 · Cited by 502
Low Plasma Adiponectin Levels and Risk of Colorectal Cancer in Men: A Prospective Study
Wei, E. K., Giovannucci, E., Fuchs, C. S., Willett, W. C., & Mantzoros, C. S. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji376 · Cited by 492
Obesity and cancer risk: the role of the insulin-IGF axis
Renehan, A. G., Frystyk, J., & Flyvbjerg, A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.08.006 · Cited by 480
Gavrila, A., Chan, J. L., Yiannakouris, N., Kontogianni, M., Miller, L. C., Orlova, C., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030214 · Cited by 441
Obesity and cancer: Pathophysiological and biological mechanisms
Renehan, A. G., Roberts, D. L., & Dive, C. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801954303 · Cited by 402
Fasting glucose is a risk factor for breast cancer: a prospective study.
Muti, P. C., Quattrin, T., Grant, B. J. B., Krogh, V., Micheli, A., Schünemann, H. J., Ram, M., Freudenheim, J. L., Sieri, S., Trevisan, M., et al. (2002) · PubMed · Cited by 396
Central obesity and breast cancer risk: a systematic review
Harvie, M., Hooper, L., & Howell, A. H. (2003) · Obesity Reviews · doi:10.1046/j.1467-789x.2003.00108.x · Cited by 391
Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence
Barb, D., Williams, C. J., Neuwirth, A. K., & Mantzoros, C. S. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.858s · Cited by 338
Serum adiponectin and leptin levels in Taiwanese breast cancer patients
Chen, D.-C., Chung, Y.-F., Yeh, Y.-T., Chaung, H.-C., Kuo, F.-C., Fu, O.-Y., Chen, H.-Y., Hou, M.-F., & Yuan, S.-S. F. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.05.047 · Cited by 328
Insulin and related factors in premenopausal breast cancer risk
Del Giudice, M. E., Fantus, I. G., Ezzat, S., McKeown-Eyssen, G., Page, D., & Goodwin, P. J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005831013718 · Cited by 304
Ligibel, J. A., Campbell, N., Partridge, A., Chen, W. Y., Salinardi, T., Chen, H., Adloff, K., Keshaviah, A., & Winer, E. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7357 · Cited by 289
Plasma Adiponectin Concentrations and Risk of Incident Breast Cancer
Tworoger, S. S., Eliassen, A. H., Kelesidis, T., Colditz, G. A., Willett, W. C., Mantzoros, C. S., & Hankinson, S. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1975 · Cited by 284
Novosyadlyy, R., Lann, D. E., Vijayakumar, A., Rowzee, A., Lazzarino, D. A., Fierz, Y., Carboni, J. M., Gottardis, M. M., Pennisi, P. A., Molinolo, A. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2141 · Cited by 282
Adiposity and Sex Hormones in Postmenopausal Breast Cancer Survivors
McTiernan, A., Rajan, K. B., Tworoger, S. S., Irwin, M., Bernstein, L., Baumgartner, R., Gilliland, F., Stanczyk, F. Z., Yasui, Y., & Ballard-Barbash, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.057 · Cited by 278
Self-citationWang, Y., Lam, J. B., Lam, K. S. L., Liu, J., Lam, M. C., Hoo, R. L. C., Wu, D., Cooper, G. J. S., & Xu, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1969 · Cited by 270
Effects of Exercise on Adiponectin: A Systematic Review
Simpson, K. A., & Singh, M. A. F. (2008) · Obesity · doi:10.1038/oby.2007.53 · Cited by 264
Caan, B. J., Kwan, M. L., Hartzell, G., Castillo, A., Slattery, M. L., Sternfeld, B., & Weltzien, E. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9203-0 · Cited by 246
Metabolic syndrome as a prognostic factor for breast cancer recurrences
Pasanisi, P., Berrino, F., De Petris, M., Venturelli, E., Mastroianni, A., & Panico, S. (2006) · International Journal of Cancer · doi:10.1002/ijc.21812 · Cited by 244
Petrelli, J. M., Calle, E. E., Rodriguez, C., & Thun, M. J. (2002) · Cancer Causes & Control · doi:10.1023/a:1015288615472 · Cited by 228
Total and High-Molecular-Weight Adiponectin in Breast Cancer:In Vitro and in Vivo Studies
Körner, A., Pazaitou-Panayiotou, K., Kelesidis, T., Kelesidis, I., Williams, C. J., Kaprara, A., Bullen, J., Neuwirth, A., Tseleni, S., Mitsiades, N., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1858 · Cited by 222
Metformin in Breast Cancer: Time for Action
Goodwin, P. J., Ligibel, J. A., & Stambolic, V. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1630 · Cited by 200
Effects of adiponectin on breast cancer cell growth and signaling
Grossmann, M. E., Nkhata, K. J., Mizuno, N. K., Ray, A., & Cleary, M. P. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604166 · Cited by 198
Lawlor, D. A., Smith, G. D., & Ebrahim, S. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000024225.14618.a8 · Cited by 182
Ryan, A. S., Nicklas, B. J., Berman, D. M., & Elahi, D. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802387 · Cited by 174
Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell
Kang, J. H., Lee, Y. Y., Yu, B. Y., Yang, B. S., Cho, K. H., Yoon, D. K., & Roh, Y. K. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02978210 · Cited by 171
Hyperadiponectinaemia in anorexia nervosa
Delporte, M., Brichard, S. M., Hermans, M. P., Beguin, C., & Lambert, M. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01702.x · Cited by 151
Waist-to-Hip Ratio and Breast Cancer Mortality
Borugian, M. J. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg236 · Cited by 137
General and Abdominal Obesity and Survival among Young Women with Breast Cancer
Abrahamson, P. E., Gammon, M. D., Lund, M. J., Flagg, E. W., Porter, P. L., Stevens, J., Swanson, C. A., Brinton, L. A., Eley, J. W., & Coates, R. J. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0356 · Cited by 134
Is it Time to Test Metformin in Breast Cancer Clinical Trials?
Cazzaniga, M., Bonanni, B., Guerrieri‐Gonzaga, A., & DeCensi, A. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0871 · Cited by 134
Chappell, S. A., Owens, G. C., & Mauro, V. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106008200 · Cited by 124
Effect of Insulin on Cell Cycle Progression in MCF-7 Breast Cancer Cells
Chappell, J., Leitner, J. W., Solomon, S. R., Golovchenko, I., Goalstone, M. L., & Draznin, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104416200 · Cited by 110
Anthropometric measures, plasma adiponectin, and breast cancer risk
Tian, Y.-F., Chu, C.-H., Wu, M.-H., Chang, C.-L., Yang, T., Chou, Y., Hsu, G., Yu, C., Yu, J., & Sun, C. (2007) · Endocrine Related Cancer · doi:10.1677/erc-06-0089 · Cited by 106
Fenton, J. I., Birmingham, J., Hursting, S. D., & Hord, N. G. (2008) · International Journal of Cancer · doi:10.1002/ijc.23436 · Cited by 89
Hébert, J. R., Augustine, A., Barone, J., Kabat, G. C., Kinne, D. W., & Wynder, E. L. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420302 · Cited by 87
Adipocytokines in Anorexia Nervosa: a Review Focusing on Leptin and Adiponectin
Brichard, S., Delporte, M., & Lambert, M. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2003-41353 · Cited by 82
Body Weight Correlates With Mortality in Early-Stage Breast Cancer
Enger, S. M., Greif, J. M., Polikoff, J., & Press, M. (2004) · Archives of Surgery · doi:10.1001/archsurg.139.9.954 · Cited by 77
Prediagnostic Adiponectin Concentrations and Pancreatic Cancer Risk in Male Smokers
Stolzenberg‐Solomon, R. Z., Weinstein, S. J., Pollak, M., Tao, Y., Taylor, P. R., Virtamo, J. R. K., & Albanes, D. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn221 · Cited by 70
Ligibel, J. A., Giobbie‐Hurder, A., Olenczuk, D. M., Campbell, N., Salinardi, T. C., Winer, E. P., & Mantzoros, C. S. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9358-3 · Cited by 66
Insulin and Hybrid Insulin/IGF Receptors Are Major Regulators of Breast Cancer Cells
Frasca, F., Pandini, G., Vigneri, R., & Goldfine, I. D. (2003) · Breast Disease · doi:10.3233/bd-2003-17108 · Cited by 62
Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points
Majed, B., Moreau, T., & Asselain, B. J. R. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0065-7 · Cited by 39
Vázquez‐Martín, A., Oliveras‐Ferraros, C., Barco, S. D., Martı́n-Castillo, B., & Menéndez, J. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.5456 · Cited by 35
Cited by
Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation
Iyengar, N. M., Gucalp, A., Dannenberg, A. J., & Hudis, C. A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.4283 · Cited by 1,004
Physical Activity, Biomarkers, and Disease Outcomes in Cancer Survivors: A Systematic Review
Ballard-Barbash, R., Friedenreich, C. M., Courneya, K. S., Siddiqi, S. M., McTiernan, A., & Alfano, C. M. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs207 · Cited by 831
Self-citationThe Role of Adiponectin in Cancer: A Review of Current Evidence
Dalamaga, M., Diakopoulos, K. N., & Mantzoros, C. S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1015 · Cited by 640
Morris, P. G., Hudis, C. A., Giri, D., Morrow, M., Falcone, D. J., Zhou, X. K., Du, B., Brogi, E., Crawford, C. B., Kopelovich, L., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0110 · Cited by 465
Metformin in cancer: translational challenges
Dowling, R. J. O., Niraula, S., Stambolic, V., & Goodwin, P. J. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0007 · Cited by 355
Metadata
- Authors
- Duggan, C., Irwin, M. L., Xiao, L., Henderson, K. D., Smith, A. W., Baumgartner, R. N., Baumgartner, K. B., Bernstein, L., Ballard-Barbash, R., & McTiernan, A.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-01-01
- Volume
- 29
- Issue
- 1
- Pages
- 32-39
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2151396655
- Cited by
- 294
- References
- 58
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.